Bank Of America Is Impressed By Takeaways From Vertex Pharmaceuticals Conference Call
October 14, 2014 at 07:59 AM EDT
In a report published Tuesday, Bank of America analyst Ying Huang reiterated a Neutral rating and $119.00 price target on Vertex ...
